Letter from President of theBoardof Directors
I amhonored toaccept this newpositionas President of theBoard. As I beginmy journey in this
leadership role, I am inspiredbyhow far theorganizationhas come in the last 15 yearswitha small staff
anddedicatedmembers of theBoard. I amcommitted toworkingcollaborativelywithmy fellowBoard
members and theCLF staff tocontinue the innovationand initiatives tobringeducationand support to
peoplearound theworldaswell as growour researchprogram toallowus to support thecritical workof
thededicated investigators trying to findanswers to themanyquestions about this disease.
Aswe look tonext year, wewill continue to serve thosewhoneedusmost byproviding the knowledge
and resources related to treatment, qualityof lifeandensure that patients arearmedwithasmuch
informationas possible tomake important and informed treatment decisions alongwith theirmedical
team. Newand innovative initiatives areon thehorizon thatwill enablemorepeople toconnect to
theCLF inameaningful wayalongwithcontinuing theCLARIONS researchgrant program to support
importantworknecessary tounlock themysteries aroundcutaneous lymphoma that canhelp findnew
treatments andbetterways for earlier diagnosis.
Eachday, aswe fight against this rarediseaseandall of its challenges, the staff andBoard keep inmind
that there is an individual behind thediagnosiswho looks tous toprovide support, sound informationand
hope.Witheach step forward, andeach individual we touch,wecontinue todedicateour efforts to
servingall people impactedbycutaneous lymphoma.
Thank you for beingan integral part of our community. Togetherwecanbridge the knowledgegapand
strive towarda timewhenadiagnosis of cutaneous lymphoma is nothingmore thanabrief detour ina
longand rich life.
Joe Eischens, Esq.
President, CLF Boardof Directors
Contents:
Boardof Directors& Staff.............................................4
AYear inReview............................................................6
Financials........................................................................8
Donors...........................................................................10
All Donors......................................................................11
Looking Forward..........................................................15
3
